Abstract:OBJECTIVE:To determine whether there are any associations between the -258T/G polymorphism of the promoter and the IVS3 -20T/C polymorphism in parkin gene and Parkinson's disease (PD) from a Han population in Sichuan province.METHODS:Polymerase chain reaction (PCR), restriction fragment length polymorphism, denaturing high performance liquid chromatography(dHPLC) and sequence analysis were used to determine the genotype of each subject. The -258T/G polymorphism and IVS3 -20T/C polymorphism were analysed in 198 patients with sporadic PD and 187 healthy controls, matched for age and gender.RESULTS:There were significant differences in allele frequency of the -258T/G polymorphism between PD patients and controls, with the G allele more common in cases than controls (52.5% vs 43.3%; chi square is 6.17, P< 0.025, OR is 1.45, 95% CI 1.04-1.86). There were also significant differences in G allele frequency between PD patients with onset age over 50 years old and controls(chi square is 9.048, P< 0.01, OR is 1.57, 95% CI:1.08-2.06). The frequency of TG+GG genotype was significantly higher in PD patients than in controls (78.79% vs 69.51%; chi square is 3.854, P< 0.05, OR is 1.63, 95% CI:0.88-2.38). In addition, there were significant differences in age of onset between PD patients with different genotypes (P< 0.05). The average age of onset in group of GG genotype was later about 5 years compared with the group of TT or TG genotype. The frequency of CC genotype in IVS3 -20T/C polymorphism was much higher than that of TC genotype. No TT genotype was found.CONCLUSION:This study suggests that the parkin promoter -258T/G polymorphism might be a risk factor for late onset PD in Sichuan. CC genotype for IVS3 -20T/C polymorphism is common in Sichuan Han population. No TT genotype for IVS3 -20T/C polymorphism is found in Sichuan Han population.

Genetic Analysis of the Fbxo48 Gene in Chinese Han Patients with Parkinson Disease

Genetic Analysis of the CHCHD2 Gene in a Cohort of Chinese Patients with Parkinson Disease.

FBXO7 Gene Mutations May Be Rare in Chinese Early-Onset Parkinsonism Patients.

[Genetic Study of a Parkinson's Disease Pedigree Caused by Compound Heterozygous Mutations in PARK2 Gene].

Genetic Variants In The Rab7l1 And Slc41a1 Genes Of The Park16 Locus In Chinese Parkinson'S Disease Patients

Genetic Analysis of ATP13A2, PLA2G6 and FBXO7 in a Cohort of Chinese Patients with Early-Onset Parkinson's Disease.

Mutation Analysis of Parkin and PINK1 Genes in Early-Onset Parkinson's Disease in China

Genetic Analysis of the Fused in Sarcoma Gene in Chinese Han Patients with Parkinson's Disease.

Association Analysis and Polygenic Risk Score Evaluation of 38 Gwas-Identified Loci in A Chinese Population with Parkinson'S Disease

An Association Between the PARK16 Locus and Parkinson’s Disease in a Cohort from Eastern China

Genetic Screening for Mutations in the Nrdp1 Gene in Parkinson Disease Patients in a Chinese Population

Genetic Analysis of SNCA Coding Mutation in Chinese Han Patients with Parkinson Disease

Association of <i>ZNF184</i>, <i>IL1R2</i>, <i>LRRK2</i>, <i>ITPKB</i>, and <i>PARK16</i> with sporadic Parkinson's disease in Eastern China

A genetic analysis of Chinese patients with early-onset Parkinson’ s disease

Analysis of Rare Variants of Autosomal‐dominant Genes in a Chinese Population with Sporadic Parkinson’s Disease

Association of Parkinson's disease with six single nucleotide polymorphisms located in four PARK genes in the northern Han Chinese population.

Lack of Association Between Three Single Nucleotide Polymorphisms in the Park9, Park15, and Bst1 Genes and Parkinson'S Disease in the Northern Han Chinese Population

[Association Analysis of the Parkin Gene in Patients with Sporadic Parkinson's Disease from a Han Population of Sichuan Province].

Analysis of 12 GWAS-Linked Loci With Parkinson’s Disease in the Chinese Han Population

No Association of FAM47E Rs6812193, SCARB2 Rs6825004 and STX1B Rs4889603 Polymorphisms with Parkinson's Disease in a Chinese Han Population.

Genetic analysis of transcription factors in dopaminergic neuronal development in Parkinson's disease